All In Biotech

Drug Trial Radar · NCT02741791

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder

STRIDE-1: A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects With Treatment Resistant Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Mar 24, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 312 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

312

Actual

Start

Mar 2016

Primary completion

Mar 20, 2020

Study completion Mar 20, 2020

Sponsor

Lead sponsor
Axsome Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Apr 18, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy and safety of AXS-05 relative to bupropion in subjects with treatment resistant major depressive disorder (MDD). This is a randomized, double-blind, active-controlled, 12-week, two-period study consisting of an open-label, bupropion lead-in period, and a double-blind treatment period. The trial is being conducted in subjects with treatment resistant MDD. Subjects will be considered to have treatment resistant MDD if they have had a historical inadequate response to 1 or 2 antidepressant treatments and a prospective inadequate response to treatment with bupropion during the open-label, lead-in period.

Conditions

  • Treatment Resistant Major Depressive Disorder

Interventions

  • AXS-05Drug

    AXS-05 taken daily for 6 weeks.

  • BupropionDrug

    Buproprion taken daily for 6 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Montgomery-Åsberg Depression Rating Scale (MADRS) total scoreTime frame: MADRS change from Baseline to End of Study (6 weeks)

Locations

74 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Phoenix, Arizona

  • Site not named

    Little Rock, Arkansas

  • Site not named

    Anaheim, California

  • Site not named

    Beverly Hills, California

  • Site not named

    Garden Grove, California

  • Site not named

    Oakland, California

  • Site not named

    Oceanside, California

  • Site not named

    Panorama City, California

  • Site not named

    Redlands, California

  • Site not named

    Riverside, California

  • Site not named

    San Diego, California

  • Site not named

    San Francisco, California

  • Site not named

    Sherman Oaks, California

  • Site not named

    Temecula, California

  • Site not named

    Upland, California

  • Site not named

    Colorado Springs, Colorado

  • Site not named

    Cromwell, Connecticut

  • Site not named

    Washington D.C., District of Columbia

  • Site not named

    Coral Springs, Florida

  • Site not named

    Fort Lauderdale, Florida

  • Site not named

    Fort Myers, Florida

  • Site not named

    Gainesville, Florida

  • Site not named

    Jacksonville, Florida

  • Site not named

    Lakeland, Florida

  • Site not named

    North Miami, Florida

  • Site not named

    Orlando, Florida

  • Site not named

    Pensacola, Florida

  • Site not named

    St. Petersburg, Florida

  • Site not named

    Atlanta, Georgia

  • Site not named

    Boise, Idaho

  • Site not named

    Skokie, Illinois

  • Site not named

    Shreveport, Louisiana

  • Site not named

    Baltimore, Maryland

  • Site not named

    Saint Charles, Missouri

  • Site not named

    St Louis, Missouri

  • Site not named

    Lincoln, Nebraska

  • Site not named

    Las Vegas, Nevada

  • Site not named

    Nashua, New Hampshire

  • Site not named

    Berlin, New Jersey

  • Site not named

    Cherry Hill, New Jersey

Showing 40 of 74 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.